In a 2011 meta-analysis of 6 randomized trials (1208 patients) treatment with , pts treated with PTA required an average of 0.3 fewer anti BP drugs. However, there was no difference between the two groups with regard to blood pressure, change in renal function, or the incidence of heart failure, stroke, or total mortality. Periprocedural complications associated with PTA ranged from 7 to 31 percent, with four procedure-related deaths and 12 renal artery perforations or dissections.
Source: Am Heart J 2011; 161:622.
No comments:
Post a Comment